Novartis ousted top scientists over manipulation of data for gene therapy
DOM SMITH/STAT
The pair have not been with the company since May, a disclosure that will likely amplify questions as to why Novartis delayed notifying the FDA of concerns.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario